Home / Inspections / 1291112

FDA Inspection 1291112 — Fresenius Kabi USA, LLC

Fresenius Kabi USA, LLC — FEI 1000115163

The FDA completed an inspection of Fresenius Kabi USA, LLC on August 28, 2025 in Melrose Park, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 28, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Melrose Park, IL (United States)

Facility

Other inspections at this facility

  • 1085354 (NAI Fri Mar 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 922406 (NAI Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 859170 (NAI Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 807610 (VAI Tue Nov 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 760383 (NAI Tue Dec 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources